3 Unusual Volume Movers: Advaxis Inc. (ADXS), Silicon Image Inc. (SIMG), And Exelixis Inc. (EXEL)

Posted by Steve Raasch January 29, 2015 0 Comment 1256 views

New York, NY – GDP INSIDER  – 01/29/2015.

Advaxis, Inc. (NASDAQ:ADXS) traded a whopping 4.23 million shares yesterday, way above its average daily volume of 1.94 million shares. The clinical-stage biotech traded in the range of $9.10 low and $11.08 high. ADXS, opened the session at $10.86and plunged 7.38% to end the session at $9.16. Afterhours trading was also characterized by losses as the stock dropped another $0.07 to take a final bow yesterday at $9.09.

Yesterday’s closing price put ADXS 7% below its 20-Day SMA, 33.33% below 52-week high, but the stock remained 272.36% above its 52-week low.

Is ADXS Going To Continue Selling Off Or Will Things Start Turning Around Soon? See What’s Next For ADXS With A Free Trend Report

Silicon Image, Inc. (NASDAQ:SIMG) witnessed about 6.59 million shares exchanging hands yesterday, way above its average daily volume of 2.04 million. The day saw shares of the connectivity solutions company trading between a session low of $7.26 and a high of $7.29. The stock opened yesterday’s session at $7.28 and closed at the same price, having declined 0.14% compared with the previous day’s closing price.

Yesterday’s closing price put SIMG 0.68% below its 52-week high and 77.56% above its 52-week low.

The massive trading in the stock of SIMG yesterday was triggered by acquisition news. Lattice Semiconductor (NASDAQ:LSCC) offered to buyout SIMG for $7.30 a share. The offer values the SIMG at about $600 million. The company closed yesterday’s session with a market cap of $565.87 million.

Could SIMG Continue To Fall Or Will We Find Support In The Near Future? See What Is In The Cards For SIMG With A Complementary Trend Analysis.

Exelixis, Inc. (NASDAQ:EXEL)’s trading yesterday was characterized by a larger volume than usual. About 13.48 million shares exchanged hands compared to the average daily volume of 2.73 million shares. The biotech company traded in the range of $1.79 and $2.08 and managed to gain 14.61% to end the session at $2.04. EXEL opened the session at $1.79. Afterhours trading brought in more gains, as EXEL added another $0.04 to take a final bow at $2.08.

Excitement in the stock of EXEL can be attributed to the recent news about the company extending a distribution agreement for its cancer targeted drug, Cometriq, in Europe.

Is EXEL Going To Continue To Move Higher Or Are Things About To Turn Around? See What’s In Store For EXEL With A Free Trend Report.

About UltimateStockAlerts

UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.

About Steve Raasch

Steve Raasch is a breaking news reporter for GDP insider. During his nearly two decades of editorial experience, Steve has covered a variety of topics including small business, health, personal finance, advertising, workplace issues and consumer behavior. Steve is very passionate about his work. Steve earned a master of arts degree in international relations from the Johns Hopkins University School of Advanced International Studies in Washington.

View all post by Steve Raasch Visit author's website

Write Your Comment